GlyCardial Diagnostics cierra una ronda de € 2,4 millones liderada por Caixa Capital Risc, a la que acude HealthEquity SCR

by Caixa Capital Risc

GlyCardial Diagnostics, spin-off biotecnológica del Instituto Catalán de Ciencias Cardiovasculares (ICCC), creada el pasado mes de septiembre, ha sido impulsada por la Fundación Bancaria ”la Caix...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Baker Tilly advises Business Software Gr...

by Baker Tilly

In February 2024, Business Software Group (BSG) launched a initial pub...

Photos Stream